Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

The discovery of placenta growth factor and its biological activity.

De Falco S.

Exp Mol Med. 2012 Jan 31;44(1):1-9. doi: 10.3858/emm.2012.44.1.025. Review.

2.

Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.

Kumazaki K, Nakayama M, Suehara N, Wada Y.

Hum Pathol. 2002 Nov;33(11):1069-77. Erratum in: Hum Pathol 2002 Dec;33(12):1244.

PMID:
12454810
3.

Placenta growth factor is not required for exercise-induced angiogenesis.

Gigante B, Tarsitano M, Cimini V, De Falco S, Persico MG.

Angiogenesis. 2004;7(3):277-84.

PMID:
15609082
4.
5.

Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.

Cao Y, Chen H, Zhou L, Chiang MK, Anand-Apte B, Weatherbee JA, Wang Y, Fang F, Flanagan JG, Tsang ML.

J Biol Chem. 1996 Feb 9;271(6):3154-62.

7.

Involvement of Flt-1 tyrosine kinase (vascular endothelial growth factor receptor-1) in pathological angiogenesis.

Hiratsuka S, Maru Y, Okada A, Seiki M, Noda T, Shibuya M.

Cancer Res. 2001 Feb 1;61(3):1207-13.

8.
10.

Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

Sawano A, Takahashi T, Yamaguchi S, Aonuma M, Shibuya M.

Cell Growth Differ. 1996 Feb;7(2):213-21.

11.

Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.

Viglietto G, Romano A, Manzo G, Chiappetta G, Paoletti I, Califano D, Galati MG, Mauriello V, Bruni P, Lago CT, Fusco A, Persico MG.

Oncogene. 1997 Nov 27;15(22):2687-98.

12.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
13.

Expression and localization of placenta growth factor and PlGF receptors in human meningiomas.

Donnini S, Machein MR, Plate KH, Weich HA.

J Pathol. 1999 Sep;189(1):66-71.

PMID:
10451490
14.

VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis.

Tjwa M, Luttun A, Autiero M, Carmeliet P.

Cell Tissue Res. 2003 Oct;314(1):5-14. Epub 2003 Sep 10. Review.

PMID:
13680354
15.

Redundant roles of VEGF-B and PlGF during selective VEGF-A blockade in mice.

Malik AK, Baldwin ME, Peale F, Fuh G, Liang WC, Lowman H, Meng G, Ferrara N, Gerber HP.

Blood. 2006 Jan 15;107(2):550-7. Epub 2005 Sep 27.

16.
17.

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.

Bussolati B, Dunk C, Grohman M, Kontos CD, Mason J, Ahmed A.

Am J Pathol. 2001 Sep;159(3):993-1008.

18.
19.

Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.

Carmeliet P, Moons L, Luttun A, Vincenti V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D, Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A, Blacher S, VandenDriessche T, Ponten A, Eriksson U, Plate KH, Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM, Collen D, Persico MG.

Nat Med. 2001 May;7(5):575-83.

PMID:
11329059
20.

Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.

Odorisio T, Schietroma C, Zaccaria ML, Cianfarani F, Tiveron C, Tatangelo L, Failla CM, Zambruno G.

J Cell Sci. 2002 Jun 15;115(Pt 12):2559-67.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk